BEI Medical Plans Year 2000 PMA Filing For Endometrial HydroThermAblator
This article was originally published in The Gray Sheet
Executive Summary
BEI Medical Systems is on target to complete Phase III studies of its Hydro ThermAblator system for thermal endometrial ablation in the first quarter.
You may also be interested in...
Gynecologists Likely To Have New Options For Treating Menorrhagia In 2001
BEI Medical Systems' Hydro ThermAblator (HTA) system for endometrial ablation will provide a new option for gynecologists in the treatment of menorrhagia when it becomes available, likely in early 2001.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.